Evidence map›Paper›PMID 33363588›Full record

ArticleExperimental and therapeutic medicine2021

Epidemiological profile of systemic sclerosis in the southeast region of Romania.

Carmen Bobeica, Elena Niculet, Mihaela Craescu, Cristian Onisor, Florin Bujoreanu, Miruna Luminita Draganescu, Ioana Alina Halip, Laura Gheuca-Solovastru

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Predictive value of immunological markers in systemic sclerosis.Experimental and therapeutic medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carmen BobeicaDepartment of Dermato‑Venereology, 'Gr. T. Popa' Doctoral School University of Medicine and Pharmacy, Iași 700115, Romania.
Elena NiculetDepartment of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, 'Dunărea de Jos' University, Galați 800216, Romania.
Mihaela CraescuDepartment of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, 'Dunărea de Jos' University, Galați 800216, Romania.
Cristian OnisorDepartment of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, 'Dunărea de Jos' University, Galați 800216, Romania.
Florin BujoreanuDepartment of Clinical Dermato‑Venereology, 'Sf. Cuvioasă Parascheva' Infectious Diseases Clinical Hospital, Galați 800179, Romania.
Miruna Luminita DraganescuDepartment of Clinical Infectious Diseases, 'Dunărea de Jos' University, Faculty of Medicine and Pharmacy, Galați 800216, Romania.
Ioana Alina HalipDepartment of Dermato‑Venereology, 'Gr. T. Popa' Doctoral School University of Medicine and Pharmacy, Iași 700115, Romania.
Laura Gheuca-SolovastruDepartment of Clinical Dermato-Venereology, 'Gr. T. Popa' University of Medicine and Pharmacy, Faculty of Medicine and Pharmacy, Iași 700115, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic sclerosis (SSc) is a collagenosis, in which the microvasculature of the skin and internal organs becomes affected, followed by excessive deposition of connective tissue. It has been included in the group of rare diseases, and it seems to have had an increasing incidence over the last two decades. Statistics show, not only an increase in the incidence of SSc, but that of autoimmune diseases as a whole. The present study aimed to outline the epidemiological profile of SSc in the southeast region of Romania and to identify similarities and differences concerning the epidemiology of this disease in other countries. The current observational study was carried out on a group of 22 patients who were diagnosed with SSc and who were hospitalized at a university clinic in Bucharest. Our research revealed a higher prevalence of women suffering from SSc, with higher numbers suffering from the diffuse subset of this disease. In addition, we found that the majority of patients came from urban areas. SSc has an important impact on the quality of life of patients, thus opening the opportunity for studies to be carried out on larger populations of patients in order to identify epidemiological similarities and differences in various countries, as well as finding new experimental models useful for future research.

Indexed as

autoimmunecollagenosisepidemiological profilemicrovasculopathyskin fibrosissystemic sclerosis

Identifiers

PMID33363588
PMCPMC7725015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.